Scarica l'app Stockscreener
4.04
1.46%
-0.06
Dopo l'orario di chiusura:
4.01
-0.03
-0.74%
Precedente Chiudi:
$4.10
Aprire:
$4.22
Volume 24 ore:
2.57M
Relative Volume:
0.66
Capitalizzazione di mercato:
$729.26M
Reddito:
-
Utile/perdita netta:
$-217.44M
Rapporto P/E:
-1.8618
EPS:
-2.17
Flusso di cassa netto:
$-205.20M
1 W Prestazione:
-4.04%
1M Prestazione:
+19.88%
6M Prestazione:
+176.71%
1 anno Prestazione:
+40.28%
Intervallo 1D:
$3.95
$4.24
Intervallo di 1 settimana:
$3.95
$4.42
Portata 52W:
$1.11
$6.94
Prime Medicine Inc Stock (PRME) Company Profile
Nome
Prime Medicine Inc
Settore
Industria
Telefono
617-465-0013
Indirizzo
60 FIRST ST., CAMBRIDGE
Confronta PRME con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PRME
Prime Medicine Inc
|
4.04 | 740.09M | 0 | -217.44M | -205.20M | -2.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Prime Medicine Inc Stock (PRME) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-27 | Downgrade | Citigroup | Buy → Neutral |
| 2025-05-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-05-20 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-12-10 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-05-20 | Iniziato | H.C. Wainwright | Buy |
| 2024-05-16 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-04-22 | Iniziato | Chardan Capital Markets | Buy |
| 2024-04-08 | Iniziato | TD Cowen | Buy |
| 2024-04-03 | Iniziato | Wedbush | Outperform |
| 2024-01-16 | Downgrade | Stifel | Buy → Hold |
| 2023-12-08 | Iniziato | Citigroup | Neutral |
| 2023-10-09 | Iniziato | BMO Capital Markets | Outperform |
| 2023-07-31 | Iniziato | Guggenheim | Buy |
| 2023-04-18 | Iniziato | Stifel | Buy |
| 2022-11-14 | Iniziato | Goldman | Neutral |
| 2022-11-14 | Iniziato | JP Morgan | Overweight |
| 2022-11-14 | Iniziato | Jefferies | Buy |
| 2022-11-14 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Prime Medicine Inc Borsa (PRME) Ultime notizie
Prime Medicine's Market Cap Up US$161m Following Year Of Insider Stock Buying - simplywall.st
Prime Medicine’s Stock Fluctuations: How Genomic Advances Steer Performance - StocksToTrade
Prime Medicine (NYSE:PRME) Shares Gap UpShould You Buy? - MarketBeat
Prime Medicine (NASDAQ:PRME) Shares Gap UpStill a Buy? - MarketBeat
Prime Medicine announces NEJM publication of PM359 data - TipRanks
Prime Medicine Announces The New England Journal of - GlobeNewswire
Prime Medicine (Nasdaq: PRME) reports first-in-human PM359 CGD data in NEJM study - Stock Titan
Prime Medicine, Inc. (PRME) Reports Q1 Loss, Misses Revenue Estimates - sharewise.com
Prime Medicine (NYSE:PRME) Stock Price Up 10.2%Still a Buy? - MarketBeat
Prime Medicine (NASDAQ:PRME) Trading Up 11.1%Here's What Happened - MarketBeat
Will Prime Medicine Inc. stock deliver better than expected guidance2025 Sector Review & Safe Capital Preservation Plans - Newser
Prime Medicine (PRME) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Prime Medicine (NASDAQ:PRME) Stock Price Down 7.3%Here's What Happened - MarketBeat
Prime Medicine (NYSE:PRME) Stock Price Down 7.2%Here's Why - MarketBeat
PRME: Prime editing advances with focused clinical programs and data expected in 2027 - TradingView — Track All Markets
Prime Medicine (PRME) Competitors and Alternatives 2025 - MarketBeat
Prime Medicine, Inc. (NYSE:PRME) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Prime Medicine to Present at 8th Annual Evercore Healthcare Conference - The Manila Times
Prime Medicine, Inc. (PRME) Reports Q3 Loss, Lags Revenue Estimates - MSN
Prime Medicine transferred with Neutral rating at JPMorgan - MSN
How interest rate cuts could boost Prime Medicine Inc. stockQuarterly Trade Summary & Intraday High Probability Alerts - newser.com
How strong is Prime Medicine Inc. stock balance sheetRate Hike & Growth Oriented Trading Recommendations - newser.com
Prime Medicine Target of Unusually High Options Trading (NYSE:PRME) - MarketBeat
How Prime Medicine Inc. stock reacts to job market dataJuly 2025 Analyst Calls & Daily Oversold Stock Bounce Ideas - newser.com
Momentum divergence signals in Prime Medicine Inc. chartJuly 2025 Update & Trade Opportunity Analysis - newser.com
Prime Medicine’s Surprising Performance: Buy or Step Back? - StocksToTrade
Prime Medicine Inc. (PRME) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Published on: 2025-11-19 13:58:58 - newser.com
Prime Medicine (NASDAQ:PRME) Shares Down 5.8%What's Next? - MarketBeat
Prime Medicine (NYSE:PRME) Trading Down 6.1%Should You Sell? - MarketBeat
Technical signs of recovery in Prime Medicine Inc.July 2025 Intraday Action & Daily Stock Trend Reports - newser.com
Tick level data insight on Prime Medicine Inc. volatilityJuly 2025 Retail & Technical Confirmation Trade Alerts - newser.com
Prime Medicine (NASDAQ:PRME) Shares Up 7.7%Should You Buy? - MarketBeat
Is Prime Medicine Inc. stock supported by strong fundamentalsEarnings Risk Summary & Real-Time Volume Analysis Alerts - newser.com
Is Prime Medicine Inc. stock a buy in volatile marketsWeekly Profit Analysis & High Return Stock Watch Alerts - newser.com
Published on: 2025-11-17 03:08:19 - newser.com
FY2025 EPS Estimate for Prime Medicine Increased by Analyst - MarketBeat
Prime Medicine Inc Azioni (PRME) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):